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National Measles Outbreak 
The United States is currently experiencing a large, multi-state outbreak of measles linked to an amusement 
park in California.  There are no confirmed measles cases in Iowa.  
 
Measles starts with a high fever.  Soon after, it causes a cough, runny nose, and red eyes, and then 3-7 days 
after the fever a rash of tiny, red spots breaks out.  It usually starts at the head and spreads to the rest of the 
body.  The rash can last for a week, and coughing can last for 10 days.  
 
The best way to prevent measles is to get the measles-mumps-rubella vaccine (MMR).  Two doses of MMR 
vaccine will provide over 99% of people long term protection against measles.  The first dose of vaccine is 
routinely recommended between 12-15 months of age.  The second dose is usually administered at school 
entry, between 4-6 years of age, but can be administered as soon as 28 days after the first dose.  Iowa school 
law requires two doses of measles, rubella containing vaccine upon enrollment.  Generally, persons who 
started elementary school in Iowa after 1991 and were up-to-date on all school entry vaccine requirements 
have received two doses of MMR vaccine.  
 
Measles Vaccine Recommendations  
 The Advisory Committee on Immunization Practices (ACIP) recommends adults born in 1957 or later 
receive at least one documented dose of MMR vaccine or have laboratory confirmation of immunity or 
disease to be considered immune.  A second dose of MMR vaccine is also recommended for adults in 
this age category traveling internationally or students in a post-secondary institution to be considered 
immune.  
 It is assumed persons born in the U.S. prior to 1957 were likely infected with the measles virus 
therefore have presumptive immunity.   
 All health care providers, regardless of year of birth, should have 2 documented doses of MMR vaccine, 
proof of immunity (positive IgG result on serology), or laboratory confirmation of disease. 
 Killed measles vaccine, or vaccine of unknown type, administered between 1963 and 1967 did not 
provide long-lasting protection.  Doses given during that time should not count as valid doses.  Anyone 
with doses of measles vaccine documented during this timeframe should be revaccinated. 
 If someone is unable to verify prior history of illness or vaccination, it would be appropriate to 
vaccinate the individual.  Vaccination in those who have already had measles or have already received 
the recommended vaccination is not harmful; it only boosts immunity. 
 
The Iowa Department of Public Health has measles information and resources available for health care 
providers and the general public here. 
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Pneumonia Vaccine Covered by Medicare 
On September 19, 2014, the Centers for Disease Control and Prevention (CDC) published recommendations 
regarding the use of pneumococcal vaccines for adults 65 years and older.  These recommendations include 
the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and 23-Valent Pneumococcal Polysaccharide Vaccine 
(PPSV23).  For more information on these recommendations, visit 
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6337a4.htm on the CDC website. 
 
The Centers for Medicare and Medicaid Services (CMS) is updating the Medicare coverage requirements to 
align with the updated Advisory Committee on Immunization Practices (ACIP) recommendations.  Effective for 
dates of service on or after September 19, 2014, and upon implementation of CR9051 on February 2, 2015, 
Medicare will cover: 
• An initial pneumococcal vaccine to all Medicare beneficiaries who have never received the vaccine 
under Medicare Part B; and 
• A different, second pneumococcal vaccine one year after the first vaccine was administered (if 11 full 
months have passed following the month in which the last pneumococcal vaccine was administered).  
  
Note that Medicare Administrative Contractors (MACs) will not search for and adjust any claims for 
pneumococcal vaccines and their administration, with dates of service on and after September 19, 2014.  
However, they may adjust such claims brought to their attention. 
  
The complete CMS Update can be found here.  For more information on pneumococcal vaccination, please 
click here.  
 
 
Birth Dose Honor Roll  
A fifth Iowa hospital has been included in the Immunization Action Coalition’s (IAC) Hepatitis B Birth Dose 
Honor Roll.  Congratulations to St. Anthony Regional Hospital, Carroll, who reported a birth dose coverage rate 
of 97% from 1/1/2012 to 12/31/2013.  
 
Mary Greeley Medical Center, Ames, has reported a second year birth dose coverage rate of 94% from 
1/1/2014 to 12/31/2014.  Myrtue Medical Center, Harlan, has reported a second year birth dose coverage rate 
of 96% from 7/1/2013 to 6/30/2014.  These are the first Iowa hospitals to be included on IAC’s Hepatitis B 
Birth Dose Honor Roll two years in a row.  
 
The Hepatitis B Birth Dose Honor Roll was created in July of 2013 to recognize hospitals and birth centers who 
achieved 90% or greater coverage rate of administering hepatitis B vaccine prior to discharge.  To protect 
newborns from hepatitis B viral infection, birthing institutions who qualify must also implement written 
policies, procedures, and protocols including the following: 
• A standing order to administer the hepatitis B vaccine to all infants is included as a part of routine 
newborn admission orders. 
• All newborns routinely receive hepatitis B vaccine after birth, prior to discharge. 
• Mother’s HBsAg screening test result is reviewed, and original result is included in her chart as well as in 
infant’s chart. 
• If incorrect test was ordered or is missing, an HBsAg blood test is ordered ASAP for the mother. 
• Infants born to HBsAg-positive mothers receive hepatitis B immune globulin (HBIG) and hepatitis B 
vaccine within 12 hours of birth. 
Vaccine Highlights 
• Notification to the state or county health department’s perinatal hepatitis B prevention program prior 
to discharge for all mothers whose HBsAg test result is positive. 
• Infants born to mothers whose HBsAg status is unknown receive hepatitis B vaccine within 12 hours of 
birth. 
• Infants who weigh less than 2,000 grams who are born to mothers whose HBsAg status is unknown 
receive HBIG within 12 hours of birth. 
 
More information about the Hepatitis B birth Dose Honor Roll is available at 
http://www.immunize.org/honor-roll/birthdose/ or call Kelli Smith at (800)831-6293, extension 2. 
 
 
Updated Immunization Schedules 
The 2015 Childhood Immunization Schedule and the 2015 Adult Immunization Schedule are now available.  
Annually, the Advisory Committee on Immunization Practices (ACIP) develops recommendations for routine 
use of vaccines in children, adolescents, and adults. 
 
 A summary of this year’s changes can be found at www.cdc.gov/mmwr/pdf/wk/mm6404.pdf. 
 
 
 
 
IRIS Webinars 
Mark your calendars for upcoming IRIS Q&A webinars!   The webinars will not include a formal presentation.  
Instead, attendees will have the opportunity to ask staff questions about all aspects of the IRIS application.  
Registration links can be found on the IRIS website.  
 
• Thursday, March 12th 10:00 AM – 11:00 AM 
• Thursday, April 16th 2:00 PM – 3:00 PM 
• Wednesday, May 20th 10:00 AM – 11:00 AM 
  
IRIS Update 
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Save the Dates 
October 28-29, 2015 
 
EPIDEMIOLOGY & PREVENTION OF VACCINE-PREVENTABLE DISEASES 
(CDC PINK BOOK COURSE) 
& 
2015 IOWA IMMUNIZATION CONFERENCE  
Veterans Memorial 
Community Choice Credit Union Convention Center 
833 5th Street, Des Moines, Iowa 50309 
 
Epidemiology & Prevention of Vaccine-Preventable Diseases - October 28, 2015 
Faculty from the CDC's National Center for Immunization and Respiratory Diseases will present a live one-day 
comprehensive overview of the principles of vaccination, general recommendations, immunization strategies 
for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent 
them.  Continuing Education will be offered.  
 
2015 Iowa Immunization Conference - October 29, 2015 
Hear renowned speakers share the latest information on immunizations and vaccine-preventable 
diseases.  Take advantage of the opportunity to network with healthcare professionals involved with 
immunization and vaccine-preventable diseases.  Continuing Education will be offered.  
 
Featured Presenters 
• Paul Offit, MD   Children’s Hospital of Philadelphia 
• Wendy Swanson, MD   Seattle Children’s Hospital 
• Noel Brewer, PhD   University of North Carolina; Director of Cervical-Free Cancer North Carolina 
• Sandra Fryhofer, MD   Adjunct Associate Professor of Medicine at Emory University; ACIP member 
• Karen Ernst   Director, Voices for Vaccines 
• William Atkinson, MD  Immunization Action Coalition, Associate Director for Immunization Education 
 
Who Should Attend 
The Epidemiology & Prevention of Vaccine-Preventable Diseases Course and Iowa Immunization Conference 
are designed to be of interest to a diverse field of health care professionals, including: nurses, nurse 
practitioners, pharmacists, medical assistants, public health staff, physicians, physician assistants, medical and 
nursing students, and anyone interested in learning more about immunizations.  

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VFC Eligibility  
The VFC program requires patient eligibility screening and documentation at each immunization visit.  
Children from birth through 18 years of age who meet at least one of the following criteria are eligible to 
receive VFC vaccine: 
 Medicaid enrolled  
 Uninsured 
 American Indian or Alaskan Native 
 Underinsured - eligible to receive VFC vaccine only through a Federally Qualified Health Center (FQHC), 
Rural Health Clinic (RHC) or Local Public Health Agency (LPHA). 
 
Circumstances which determine underinsured eligibility are listed below:  
 Some insurance plans may cover all ACIP-recommended childhood vaccines but exclude certain 
combination vaccines or certain products.  A child with this type of coverage would be considered 
insured and NOT eligible for VFC because all recommended vaccines are covered.  
 Some insurance plans may cover a portion of the cost of the vaccine even though it may be only a 
small portion of the cost of the vaccine, so this child is considered insured for the purpose of the VFC 
Program and is NOT eligible for the program.  
 Children enrolled in hawk-i are NOT eligible under the VFC Program because the hawk-i Program is a 
full coverage insurance plan.  Children enrolled in hawk-i must be vaccinated with private vaccine.  
 Some insurance plans limit the coverage to a specific number of provider visits annually.  If a child’s 
insurance will not cover the cost of vaccine after the child has exceeded the number of provider visits, 
the child can be considered underinsured for the purposes of the VFC Program because the insurance 
would not cover the vaccine.  
 Children whose health insurance covers the cost of vaccinations are NOT eligible for VFC Program 
benefits even when a claim for the cost of the vaccine and its administration would be denied if 
submitted to the insurance carrier for payment because the plan’s deductible (high deductible plan) 
had not been met.  
 Adolescents through 18 years of age who do not know their insurance status and who present at family 
planning clinics for contraceptive services or STD treatment can be considered uninsured for the 
purposes of the VFC Program.  A person under 19 years of age who may have insurance but because of 
the confidential circumstances for seeking services in a family planning clinic does not have access to 
insurance coverage is considered uninsured for the purposes of the VFC Program.  
 If an adolescent through 18 years of age loses access to health insurance because of incarceration, the 
minor is considered uninsured and is VFC eligible.  
  
If you have questions regarding VFC eligibility, please contact Tina Patterson at 
Tina.Patterson@idph.iowa.gov or 1-800-831-6293, ext. 4. 
  
VFC Highlights 
VFC Temperature Documentation Requirements  
Effective January 1, 2015, all Vaccines for Children providers must include the time and initials of staff 
performing the twice daily temperature checks.  Temperature logs must be maintained for three years.  For 
facilities using an electronic system to monitor temperatures remotely, the electronic system must be able to 
flag the time and initials of the staff logging in to check temperatures twice daily.  If this cannot be done, 
paper temperature logs should be used to document temperature checks.  
 
Vaccine Storage & Handling Plan  
The Vaccine Storage and Handling Plan template has been updated to reflect new requirements.  When 
conducting the annual review of your clinic’s storage and handling plan, please use the new template.  The 
new template can be found on the Iowa Immunization Program’s Storage and Handling webpage at: 
http://www.idph.state.ia.us/ImmTB/Immunization.aspx?prog=Imm&pg=Handling. 
 
 
 
 
Q: How contagious is the measles?  
A:  Measles is highly infectious and is primarily transmitted from person to person via respiratory droplets.  
Airborne transmission via aerosolized droplets has been documented in closed areas (such as an office 
examination room) for up to 2 hours after a person with measles occupied the area.  Following exposure, 
more than 90% of susceptible people develop measles.  The virus can be transmitted from 4 days before 
the rash becomes visible to 4 days after the rash appears.   
 
Q:  Can MMR be given on the same day as other live virus vaccines? 
A: Yes.  However, if two parenteral or intranasal live vaccines (MMR, varicella, LAIV and/or yellow fever) are 
not administered on the same day, they should be separated by an interval of at least 28 days.  
 
Q: If a health care worker develops a rash and low-grade fever after MMR vaccine, is s/he infectious? 
A: Approximately 5 to 15% of susceptible people who receive MMR vaccine will develop a low-grade fever 
and/or mild rash 7 to 12 days after vaccination.  However, the person is not infectious, and no special 
precautions (such as exclusion from work) are necessary. 
 
Q:  When the package insert does not match CDC’s recommended immunization schedule or minimum 
intervals, which should be followed? 
A: The Advisory Committee on Immunization Practices (ACIP) makes recommendations for vaccine use to 
the CDC.  When the CDC adopts those recommendations, they are published in the Morbidity and Mortality 
Weekly Report (MMWR).  Those recommendations represent the standard of immunization practices in the 
United States.  Occasionally, ACIP recommendations differ from those on the FDA-approved package insert.  
When this occurs, health care providers should follow the ACIP and CDC recommended and minimum 
intervals and ages.  
  
Question Corner 
  
Immunization Program Email Lists  
The Iowa Immunization Program has several email list serves available to help health care providers receive 
important and timely immunization related information.  Providers can send a blank email to the addresses 
below to receive updates directly in their inbox.  
 VFC Program: join-VFC@lists.ia.gov 
 Immunization Program:  join-IMMUNIZATION@lists.ia.gov  
 IRIS Program:  join-IRISUSERS@lists.ia.gov  
 
HPV Resources from the Iowa Immunization Program  
The Iowa Immunization Program launched a media and radio campaign regarding HPV vaccine the week of 
January 26, 2015.  Below are HPV vaccine resources available to health care providers.  If you have questions 
regarding the HPV campaign, please contact Bethany Kintigh at Bethany.Kintigh@idph.iowa.gov or 1-800-
831-6293, ext.7. 
 
 HPV Poster:  This 11x17 poster features the "HPV Vaccine is the Key" campaign theme with 
infographics regarding HPV vaccination.  The poster is recommended for health care providers and 
general public use.  It has a space at the bottom of the poster to enter facility-specific information.  The 
poster can be ordered here.  
 HPV Brochure:  This folded 3¾ x 8½ brochure outlines HPV, HPV vaccine information and 
recommendations.  It is recommended for health care providers and general public use.  The brochure 
can be ordered here.  
 HPV Webpage:  The Iowa Immunization Program has added a HPV web page with HPV resources for 
health care providers.  The page can be found here.   
 HPV Billboard Campaign:  The Iowa Immunization Program launched a billboard campaign throughout 
Iowa which will run through August 2015.  The billboard design can be found here in a PDF form which 
may be used for posters, advertising, etc. 
 HPV Radio Campaign:  Jackie’s Story features a mom who is a cancer survivor speaking on the 
importance of HPV vaccination for boys and girls starting at age 11.  The radio ad can be found here.   
 
Resources 
